Lazard Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.46M | Buy |
41,110
+2,036
| +5% | +$122K | ﹤0.01% | 943 |
|
2025
Q1 | $2.05M | Buy |
39,074
+5,782
| +17% | +$303K | ﹤0.01% | 965 |
|
2024
Q4 | $1.83M | Buy |
33,292
+8,773
| +36% | +$482K | ﹤0.01% | 916 |
|
2024
Q3 | $1.23M | Buy |
24,519
+9,005
| +58% | +$453K | ﹤0.01% | 1016 |
|
2024
Q2 | $681K | Buy |
15,514
+9,406
| +154% | +$413K | ﹤0.01% | 1089 |
|
2024
Q1 | $268K | Sell |
6,108
-210
| -3% | -$9.21K | ﹤0.01% | 1207 |
|
2023
Q4 | $299K | Buy |
6,318
+293
| +5% | +$13.9K | ﹤0.01% | 1260 |
|
2023
Q3 | $267K | Buy |
6,025
+827
| +16% | +$36.6K | ﹤0.01% | 1290 |
|
2023
Q2 | $248K | Buy |
5,198
+143
| +3% | +$6.82K | ﹤0.01% | 1287 |
|
2023
Q1 | $198K | Sell |
5,055
-637
| -11% | -$25K | ﹤0.01% | 1314 |
|
2022
Q4 | $161K | Buy |
5,692
+12
| +0.2% | +$339 | ﹤0.01% | 1346 |
|
2022
Q3 | $170K | Sell |
5,680
-44
| -0.8% | -$1.32K | ﹤0.01% | 1307 |
|
2022
Q2 | $194K | Buy |
5,724
+3,593
| +169% | +$122K | ﹤0.01% | 1293 |
|
2022
Q1 | $95K | Buy |
2,131
+68
| +3% | +$3.03K | ﹤0.01% | 1414 |
|
2021
Q4 | $95K | Buy |
+2,063
| New | +$95K | ﹤0.01% | 1460 |
|
2021
Q3 | – | Sell |
-824
| Closed | -$24K | – | 2219 |
|
2021
Q2 | $24K | Buy |
+824
| New | +$24K | ﹤0.01% | 1837 |
|
2021
Q1 | – | Sell |
-649
| Closed | -$14K | – | 1928 |
|
2020
Q4 | $14K | Sell |
649
-151
| -19% | -$3.26K | ﹤0.01% | 1751 |
|
2020
Q3 | $17K | Sell |
800
-1,015
| -56% | -$21.6K | ﹤0.01% | 1445 |
|
2020
Q2 | $42K | Sell |
1,815
-278
| -13% | -$6.43K | ﹤0.01% | 1275 |
|
2020
Q1 | $44K | Buy |
2,093
+1,357
| +184% | +$28.5K | ﹤0.01% | 1221 |
|
2019
Q4 | $17K | Buy |
736
+296
| +67% | +$6.84K | ﹤0.01% | 1270 |
|
2019
Q3 | $9K | Buy |
+440
| New | +$9K | ﹤0.01% | 1318 |
|